Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia

Study Type:Therapy

OE Level Evidence:1

Journal Level of Evidence:N/A

Fracture Prevention with Zoledronate in Older Women with Osteopenia

N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082

Contributing Authors: IR Reid S Wong MJ Bolland GD Gamble B Mihov AM Horne A Stewart E Garratt KR Wiessing S Bastin

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

No credit card required

JOIN Forgot Password?

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.